| Kinase |
Targeted Nuclear Receptor |
Targeted Residue |
Effect |
Reference |
| PKC |
PPARα |
T129, S179,S230 |
Activation |
[81] |
| ERα |
S46/47 |
Activation |
[82] |
| RARα |
S77, 157 |
Inhibition |
[83] |
| RORα |
? |
Inhibition |
[84] |
| PKA |
PPARα |
N-terminal |
Activation |
[85] |
| ERα |
S305, S236 |
Inhibition |
[86, 87] |
| RARα |
S369 |
Inhibition |
[88] |
| RARγ |
S360 |
Inhibition |
[89] |
| CK-II |
PPARγ1 |
S16, S21 |
Activation |
[90] |
| CK2 |
ERα |
S282, S559 |
Inhibition |
[82] |
| GSK3B |
ERα |
S102,S104, S106, S118 |
Activation |
[91] |
| REV-ERBα |
S55, S59 |
Activation |
[92] |
| p38 |
PPARα |
S6, S21, S12 |
Mix effect depends on cell type |
[93] |
| ERβ |
S106, S124 |
Activation |
[94] |
| GR |
S211 or S226 |
Inhibition |
[95] |
| RARγ |
S66-S68 |
Activation |
[96] |
| MAPK |
PPARγ |
S112 |
Inhibition |
[97] |
| ERα |
S118, S167 |
Activation |
[98] |
| RAS/MAPK |
ERα |
T311 |
Activation |
[86] |
| CDKs, MAPK, CKII |
GR |
S113. S141, S203, S211, S226 |
Activation |
[99] |
| ERK |
PPARα |
S12, S21 |
Activation |
[100] |
| PPARγ1 |
S84 |
Inhibition |
[101] |
| RORα |
T128 |
Activation |
[102] |
| JNK |
RXRα |
S22, S61, S75, S87 |
Inhibition |
[103] |
| RXRα |
S265 |
Inhibition |
[104] |
| AMPK |
PPARα/PPPARβ |
thought activating p38/MAPK and ERK |
Mix Effect depends on cell type |
[105-107] |
| GRα |
S211 through activating p38 |
Inhibition |
[108] |
| Other Postranstional Modification |
NR |
Modification |
Effect |
Reference |
| Multiple enzymes |
Most NR |
Acetylation |
Activation |
[109] |
| SIRT1 |
ERα |
deacetylase |
Inhibition |
[110,111] |
| PPARγ |
deacetylase |
Inhibition |
[111] |
| RAR |
Deacetylase |
Inhibition |
[112] |
| HDACs |
Most NR |
deacetylation |
Mix effect |
[109] |
|